Ladenburg, Germany

Susanne Werner-Simon

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Hüffelsheim, DE (2020 - 2023)
  • Ladenburg, DE (2021 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Susanne Werner-Simon:

Title: Innovator Spotlight: Susanne Werner-Simon Revolutionizing Cancer Treatment

Introduction:

Susanne Werner-Simon is a prolific inventor based in Ladenburg, Germany. With a remarkable portfolio of 6 patents, he is making significant strides in the field of cancer treatment through his groundbreaking innovations.

Latest Patents:

Susanne Werner-Simon's latest patents include:

1. Method of treating cancer using amanitin derivatives: This method involves synthesizing amanitin derivatives with an amino group attached to position 6′ of the central tryptophan moiety. It also encompasses the development of conjugates of such amanitin derivatives and pharmaceutical compositions comprising these conjugates.

2. Method for synthesizing amanitins: This patent introduces novel methods for synthesizing amanitin derivatives with a hydroxy group attached to the central tryptophan moiety. It further elaborates on amanitin derivatives with a hydroxy group attached to position 4′, 5′, or 7′ of the central tryptophan moiety, as well as pharmaceutical compositions containing these conjugates.

Career Highlights:

Susanne Werner-Simon is affiliated with Heidelberg Pharma Research GmbH, a leading pharmaceutical research company. His expertise and dedication have played a pivotal role in driving innovation and advancing cancer therapeutics within the organization.

Collaborations:

Susanne Werner-Simon collaborates closely with esteemed colleagues such as Werner Simon and Christoph Müller. Together, they form a formidable team that continues to push the boundaries of cancer research and treatment.

Conclusion:

In conclusion, Susanne Werner-Simon stands out as a visionary inventor at the forefront of cancer treatment innovation. His pioneering work in synthesizing amanitin derivatives is shaping the future of pharmaceutical interventions for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…